Buscar
Mostrando ítems 21-30 de 67
Análogos de insulina: en búsqueda del reemplazo fisiológico
(Sociedad Médica de Santiago, 2006)
Estudio in silico de la interacción entre la insulina glargina y los receptores IR e IGF1R
(2016-12-14)
Introducción: La glargina es un análogo de la insulina utilizado para el tratamiento de la diabetes mellitus. Se ha reportado que este análogo presenta actividad mitogénica y que podría tener relación con cáncer en algunos ...
Glucose Control in Acute Myocardial Infarction: A Pilot Randomized Study Controlled by Continuous Glucose Monitoring System Comparing the Use of Insulin Glargine with Standard of Care
(MARY ANN LIEBERT INCNEW ROCHELLE, 2012)
Background: This pilot study aimed to verify if glycemic control can be achieved in type 2 diabetes patients after acute myocardial infarction (AMI), using insulin glargine (iGlar) associated with regular insulin (iReg), ...
A study of value transitions in the basal insulin regimen for treatment of type 2 diabetes
(2016-12-07)
Type 2 diabetes is a progressive disease projected to grow tremendously in prevalence. Basal insulin analogues used to be the most efficacious treatment and last step in therapeutic intensification. Today, demographic, ...
Análogos de insulina: en búsqueda del reemplazo fisiológico
(2006)
Insulin analogues, developed by molecular engineering, have
structural changes in the A and B insulin chains. These modifications change their action
profile, rendering insulin replacement closer to physiology. Rapid ...
Efetividade clínica comparativa do análogo de Insulina Glargina com Insulina NPH para tratamento de pacientes com Diabetes Mellitus tipo 1
(Universidade Federal de Minas GeraisUFMG, 2015-08-03)
The insulin analogue glargine is dispensed, in the state of Minas Gerais, to patients with diabetes mellitus type 1 that attend to criteria of Health Secretariat of Minas Gerais (SESMG). Currently about 3200 patients are ...